IP Library › Granted Patent US 9,845,336
Granted Patent B2
US 9,845,336 · App. 15/423,985 · Granted Dec 19, 2017

Uracyl spirooxetane nucleosides

Inventors: Ioannis Nicolaos Houpis (Antwerp, BE); Tim Hugo Maria Jonckers (Heist-op-den-Berg, BE); Pierre Jean-Marie Bernard Raboisson (Rosieres, BE); Abdellah Tahri (Anderlecht, BE)
Assignee: Janssen Sciences Ireland UC
C07H19/10A61K31/7072C07H19/06C07H19/11C07H19/24
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,845,336
App. No.
15/423,985
Granted
Dec 19, 2017
Kind
B2
Abstract

The present invention relates to compounds of the formula I: including any possible stereoisomers thereof, wherein R 9 has the meaning as defined herein, or a pharmaceutically acceptable salt or solvate thereof. The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use, alone or in combination with other HCV inhibitors, in HCV therapy.

Claims (1)

1. A compound of formula

Assignments (1)
CHANGE OF NAME Recorded Dec 11, 2018
From: JANSSEN SCIENCES IRELAND UC
To: JANSSEN SCIENCES IRELAND UNLIMITED COMPANY
Reel/Frame 047747/0439 →
Priority Claims (1)
EP 12169425 · May 25, 2012 · regional
Continuity (3)
Continuation 15238553 · Aug 16, 2016
Continuation 14403587
Related Publication 20170145045A1 · May 25, 2017